Trials / Completed
CompletedNCT00481637
Study to Evaluate Immune Responses in Neurologically Normal Cancer Patients
Tumor Immunity in Neurologically Normal Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 33 (actual)
- Sponsor
- Rockefeller University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to study whether immune cells capable of killing tumors that express proteins associated with paraneoplastic neurologic syndrome (PNS) can be found in small cell lung cancer and ovarian cancer patients. The presence of these cells may play a role in tumor immunity in these patients. The protocol involves neurological examinations and collection of blood.
Detailed description
See brief description
Conditions
Timeline
- Start date
- 1998-03-01
- Primary completion
- 2013-05-01
- Completion
- 2013-05-01
- First posted
- 2007-06-04
- Last updated
- 2019-04-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00481637. Inclusion in this directory is not an endorsement.